SACRAMENTO, Calif., Sept. 06, 2017 -- IDdriven, Inc., (OTC:IDDR), an innovative provider of premises and cloud-based Identity and Access Management ("IAM") solutions is pleased to announce today that Rhode Island based health system Lifespan, selected IDdriven for its identity management and access solution.
Lifespan is the first health system of Rhode Island and operates multiple hospitals, institutes and services, with over 19,000 employees and contractors.
Major part of the decision was a reliable certification and attestation, but also the user-friendliness of the IDdriven solution played a role.
Headquartered in Providence, Rhode Island, Lifespan is one of the most highly regarded hospital care companies in the area. Lifespan is planning to have IDdriven operational at the beginning of the fourth quarter.
Arend Verweij, CEO of IDdriven, Inc. stated, “We look forward to a long relation with Lifespan. We have recently seen an increasing demand for Identity and access management solutions in the medical market. Our IDdriven solution fits in there very well.”
About IDdriven
With its next-generation IDaaS program of the same name, IDdriven, Inc. is at the forefront of the new breed of Identity Management and Access Governance solutions. Taking the complexity and upfront costs out of implementation, IDdriven automates access security for vulnerable company assets by seamlessly integrating with the solutions from Microsoft, and other cloud providers like Amazon. Founded in 2013, IDdriven is headquartered in Sacramento, California. To learn more, visit: www.IDdriven.com.
Forward-Looking Statement Disclosure
This news release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond IDdriven’ s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) commercialization of our software programs, (ii) development and protection of our intellectual property, (iii) industry competition, (iv) we may need to raise capital to meet business requirements. More detailed information about IDdriven and the risk factors that may affect the realization of forward looking statements is contained in our filings with the Securities and Exchange Commission which are available on our website and at www.sec.gov. IDdriven assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Company Contact E: [email protected] T: 415.226.7773


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



